These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6497531)

  • 1. Cerebellar ataxia due to procainamide toxicity.
    Schwartz AB; Klausner SC; Yee S; Turchyn M
    Arch Intern Med; 1984 Nov; 144(11):2260-1. PubMed ID: 6497531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electropharmacologic testing in sustained ventricular tachycardia associated with coronary heart disease: value of the response to intravenous procainamide in predicting the response to oral procainamide and oral quinidine treatment.
    Oseran DS; Gang ES; Rosenthal ME; Mandel WJ; Peter T
    Am J Cardiol; 1985 Nov; 56(13):883-6. PubMed ID: 3904387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytopenia following sustained-release procainamide.
    Meisner DJ; Carlson RJ; Gottlieb AJ
    Arch Intern Med; 1985 Apr; 145(4):700-2. PubMed ID: 2580499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained-release procainamide: use of serum concentrations to determine dosage.
    Reed WE; Cooper MW
    South Med J; 1985 Oct; 78(10):1190-3. PubMed ID: 4049036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Novocainamide in the treatment of paroxysmal supraventricular tachycardia and auricular fibrillation in premature ventricular excitation syndrome (relation between novocainamide dose, its blood level, and antiarrhythmia effect)].
    Ankhimiuk ON; Smolenskiĭ VS; Izotov BN; Andiiako TB
    Ter Arkh; 1982; 54(3):92-6. PubMed ID: 7089899
    [No Abstract]   [Full Text] [Related]  

  • 6. [Transitory cerebellar ataxia from high dosage combination thymoleptic therapy].
    Schied HW; Bartels M
    Pharmacopsychiatria; 1983 Mar; 16(2):64-7. PubMed ID: 6867095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of bisoprolol and procainamide in human cardiac impulse generation and conduction.
    Verrostte JM; van Hemel NM; Kingma JH
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S193-5. PubMed ID: 11527128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lethal arrhythmias in a patient with coarctation of the aorta and severe heart failure: their control by combination of low dose amiodarone with procainamide for 3 years].
    Shinmura K; Hasegawa H; Ishida H; Shimizu K; Ebihara Y; Koyama T; Iwanaga S; Honma S; Tani M; Handa S
    Kokyu To Junkan; 1993 Nov; 41(11):1107-11. PubMed ID: 8256053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow granulomas and neutropenia associated with procainamide. Report of a case.
    Riker J; Baker J; Swanson M
    Arch Intern Med; 1978 Nov; 138(11):1731-2. PubMed ID: 718331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pure red cell aplasia associated with administration of sustained-release procainamide.
    Giannone L; Kugler JW; Krantz SB
    Arch Intern Med; 1987 Jun; 147(6):1179-80. PubMed ID: 3036033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verapamil responsive reentrant ventricular tachycardia: a case report with electrophysiological investigation.
    Hasin Y; Kriwisky M; Gotsman MS
    Isr J Med Sci; 1982 Apr; 18(4):499-502. PubMed ID: 7085250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procainamide hydrochloride sensitivity. Manifested by fever and chills.
    Shapiro MS; Teitler A; Grob D
    Minn Med; 1973 Dec; 56(12):1041-4. PubMed ID: 4271436
    [No Abstract]   [Full Text] [Related]  

  • 13. Procainamide: a perspective on its value and danger.
    Ellenbogen KA; Wood MA; Stambler BS
    Heart Dis Stroke; 1993; 2(6):473-6. PubMed ID: 8137053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitory ataxia related to topically administered lidocaine.
    Perney P; Blanc F; Mourad G; Blayac JP; Hillaire-Buys D
    Ann Pharmacother; 2004 May; 38(5):828-30. PubMed ID: 15039479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual case of antiphospholipid antibody syndrome presenting with extensive cutaneous infarcts in a patient on long-term procainamide therapy.
    El-Rayes BF; Edelstein M
    Am J Hematol; 2003 Feb; 72(2):154. PubMed ID: 12555226
    [No Abstract]   [Full Text] [Related]  

  • 16. [Programmed stimulation in patients with malignant ventricular arrhythmia. II: Individual optimization of anti-arrhythmia therapy].
    Senges J; Lengfelder W; Jauernig R; Brachmann J; Rizos I; Kübler W
    Herz; 1984 Apr; 9(2):77-82. PubMed ID: 6714917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart failure and lactic acidosis associated with oral procainamide.
    O'Connell F; Mecher C
    Acute Care; 1988-1989; 14-15():350-2. PubMed ID: 3155037
    [No Abstract]   [Full Text] [Related]  

  • 18. Procainamide administration during pregnancy.
    Allen NM; Page RL
    Clin Pharm; 1993 Jan; 12(1):58-60. PubMed ID: 7679065
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness of pharmacological prevention after the first attack of ventricular tachycardia].
    Citone C; Di Marcotullio G; Polizzi C; Uguccioni M; Carelli M; Masini V
    Cardiologia; 1982; 27(4):399-400. PubMed ID: 6892422
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduced postoperative atrial fibrillation using multidrug prophylaxis.
    Ott RA; Gutfinger DE; Alimadadian H; Miller M; Selvan A; Weinberg D; Hlapcich WL; Tanner TM
    J Card Surg; 1999; 14(6):437-43. PubMed ID: 11021368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.